drugset / Trial / NCT00002950
Topotecan Plus Sargramostim in Treating Patients With Advanced Cancer
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Colony-stimulating factors such as sargramostim may increase the number of immune cells found in bone marrow or peripheral blood and may help a person's immune system recover from the side effects of chemotherapy. PURPOSE: Phase I/II trial to study the effectiveness of topotecan plus sargramostim in treating patients who have advanced cancer.
Timeline
- Start
- 1996-09-26
- Primary completion
- 2002-02-10
- Completion
- 2002-02-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Topotecan | Small molecule | — | Intravenous |
| Subject | sargramostim | Protein / enzyme biologic | — | — |